Published in Gastrointest Endosc on April 01, 2002
Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol (2006) 3.40
Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch (2004) 3.04
Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol (2007) 2.60
Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol (2007) 1.87
Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol (2006) 1.82
Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria. J Gastroenterol (2007) 1.57
Type 1 autoimmune pancreatitis. Orphanet J Rare Dis (2011) 1.10
High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig Dis Sci (2005) 1.10
Focal autoimmune pancreatitis: radiological characteristics help to distinguish from pancreatic cancer. World J Gastroenterol (2013) 1.10
Autoimmune pancreatitis in Japan: overview and perspective. J Gastroenterol (2009) 1.06
Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. J Gastroenterol (2008) 1.06
Autoimmune pancreatitis: a review. World J Gastroenterol (2007) 1.06
Clinical features of autoimmune pancreatitis. J Gastroenterol (2007) 1.04
Japanese consensus guidelines for management of autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol (2010) 1.01
Differentiation between autoimmune pancreatitis and pancreatic carcinoma based on endoscopic retrograde cholangiopancreatography findings. J Gastroenterol (2010) 0.99
Risk factors for pancreatic stone formation in autoimmune pancreatitis over a long-term course. J Gastroenterol (2011) 0.98
Involvement of pancreatic and bile ducts in autoimmune pancreatitis. World J Gastroenterol (2006) 0.97
Autoimmune pancreatitis: histo- and immunopathological features. J Gastroenterol (2007) 0.96
A novel immunoglobulin-immunoglobulin interaction in autoimmunity. PLoS One (2008) 0.96
Autoimmune pancreatitis associated with renal lesions mimicking metastatic tumours. CMAJ (2006) 0.95
MRCP and MRI findings in 9 patients with autoimmune pancreatitis. World J Gastroenterol (2006) 0.94
A focal mass-forming autoimmune pancreatitis mimicking pancreatic cancer with obstruction of the main pancreatic duct. J Gastrointest Surg (2011) 0.93
Pyogenic liver abscess after choledochoduodenostomy for biliary obstruction caused by autoimmune pancreatitis. World J Gastroenterol (2006) 0.92
Autoimmune Pancreatitis: A Multiorgan Disease Presenting a Conundrum for Clinicians in the West. Gastroenterol Hepatol (N Y) (2015) 0.87
Sclerosing cholecystitis associated with autoimmune pancreatitis. World J Gastroenterol (2006) 0.87
Primary sclerosing cholangitis with elevated serum IgG4 levels and/or infiltration of abundant IgG4-positive plasma cells. J Gastroenterol (2009) 0.83
Clinical analysis of 36 cases of autoimmune pancreatitis in China. PLoS One (2012) 0.83
Molecular targeting of pancreatic disorders. World J Surg (2005) 0.81
Diagnostic criteria for autoimmune chronic pancreatitis. J Gastroenterol (2007) 0.81
Serum protein signatures differentiating autoimmune pancreatitis versus pancreatic cancer. PLoS One (2013) 0.80
Endoscopic retrograde pancreatography: When should we do it? World J Gastrointest Endosc (2015) 0.79
Cholangiocarcinoma developed in a patient with IgG4-related disease. World J Gastrointest Oncol (2013) 0.79
T cell lymphoplasmacellular and eosinophilic infiltration of the pancreas with involvement of the gallbladder and duodenum in non-alcoholic duct-destructive chronic pancreatitis. Langenbecks Arch Surg (2004) 0.78
Autoimmune pancreatitis in the context of IgG4-related disease: review of imaging findings. World J Gastroenterol (2014) 0.76
Autoimmune pancreatitis. Gland Surg (2016) 0.75
Autoimmune chronic pancreatitis relapsing despite the maintenance dose of steroid. Korean J Intern Med (2005) 0.75
Autoimmune pancreatitis: Multimodality non-invasive imaging diagnosis. World J Gastroenterol (2014) 0.75
Autoimmune Pancreatitis. Gastroenterol Rep (2013) 0.75
Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol (2012) 7.39
International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas (2011) 4.56
Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum (2012) 4.27
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol (2011) 4.26
Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol (2006) 3.04
Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors. Hepatology (2008) 2.70
Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet (2002) 2.69
Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat Genet (2003) 2.67
Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol (2007) 2.60
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52
Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter (2010) 2.50
Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage. Hepatology (2004) 2.40
Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol (2008) 2.31
Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol (2010) 2.25
Operative morbidity of living liver donors in Japan. Lancet (2003) 2.13
Japanese clinical guidelines for autoimmune pancreatitis. Pancreas (2009) 2.11
Development of small hepatocellular carcinoma in a patient with chronic hepatitis C after 77 months of a sustained and complete response to interferon therapy. J Gastroenterol Hepatol (2002) 2.07
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. Cancer (2004) 2.03
Mechanisms of lower bile duct stricture in autoimmune pancreatitis. Pancreas (2014) 1.98
HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology (2002) 1.92
Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis? Gastrointest Endosc (2005) 1.81
Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci (2012) 1.72
Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer (2002) 1.69
Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am J Gastroenterol (2008) 1.67
Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori. Helicobacter (2002) 1.65
PPARalpha protects proximal tubular cells from acute fatty acid toxicity. J Am Soc Nephrol (2007) 1.62
Donor complications associated with living donor liver transplantation in Japan. Transplantation (2009) 1.60
Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology (2007) 1.58
A case of Mikulicz's disease complicated by malignant lymphoma: a postmortem histopathological finding. Intern Med (2012) 1.56
PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. J Clin Invest (2008) 1.55
Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients. Hepatol Res (2005) 1.51
Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis. Eur J Radiol (2009) 1.47
Efficacy and safety of 6-month iron reduction therapy in patients with hepatitis C virus-related cirrhosis: a pilot study. J Gastroenterol (2007) 1.45
Epidemiology of hepatocellular carcinoma in Japan. J Gastroenterol (2009) 1.44
Idiopathic myelofibrosis with refractory massive ascites. Intern Med (2003) 1.43
Comparison of carbon dioxide and air insufflation use by non-expert endoscopists during endoscopic retrograde cholangiopancreatography. Dig Endosc (2012) 1.41
Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol (2008) 1.33
Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol (2004) 1.32
IgG4-associated multifocal systemic fibrosis complicating sclerosing sialadenitis, hypophysitis, and retroperitoneal fibrosis, but lacking pancreatic involvement. Intern Med (2006) 1.28
Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan. Pancreas (2006) 1.26
Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol (2014) 1.26
Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan. Clin Infect Dis (2008) 1.25
The adherent gastric mucous layer is composed of alternating layers of MUC5AC and MUC6 mucin proteins. Dig Dis Sci (2004) 1.20
Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load. J Clin Microbiol (2002) 1.18
Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis. J Infect Dis (2003) 1.18
High salt diets dose-dependently promote gastric chemical carcinogenesis in Helicobacter pylori-infected Mongolian gerbils associated with a shift in mucin production from glandular to surface mucous cells. Int J Cancer (2006) 1.18
IL-17 is involved in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Helicobacter (2008) 1.17
Polyenephosphatidylcholine prevents alcoholic liver disease in PPARalpha-null mice through attenuation of increases in oxidative stress. J Hepatol (2009) 1.16
Autoimmune pancreatitis and complement activation system. Pancreas (2006) 1.15
Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice. Cell Transplant (2003) 1.12
Type 1 autoimmune pancreatitis. Orphanet J Rare Dis (2011) 1.10
High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig Dis Sci (2005) 1.10
Epidemiology of hepatocellular carcinoma in Japan. Hepatol Res (2007) 1.10
Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection. J Hepatol (2010) 1.09
Identification of novel HCV subgenome replicating persistently in chronic active hepatitis C patients. J Med Virol (2005) 1.09
Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related sclerosing cholangitis: a Japanese cohort. J Gastroenterol Hepatol (2013) 1.09
Possible relationship between Helicobacter pylori infection and cap polyposis of the colon. Helicobacter (2004) 1.08
Re-evaluation of melanin bleaching using warm diluted hydrogen peroxide for histopathological analysis. Pathol Int (2011) 1.07
Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. J Gastroenterol (2008) 1.06
Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis. Int J Cancer (2008) 1.06
Efficacy of preoperative endoscopic nasobiliary drainage for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg (2009) 1.05
Autoimmune pancreatitis-associated prostatitis: distinct clinicopathological entity. Pathol Int (2008) 1.05
Clinical features of autoimmune pancreatitis. J Gastroenterol (2007) 1.04
Observation of positive selection within hypervariable regions of a newly identified DNA virus (SEN virus)(1). FEBS Lett (2002) 1.04
Autoimmune pancreatitis is closely associated with gastric ulcer presenting with abundant IgG4-bearing plasma cell infiltration. Gastrointest Endosc (2004) 1.04
Corticosteroid-responsive pancreatic cyst found in autoimmune pancreatitis. J Gastroenterol (2005) 1.04
IgG4-related chronic rhinosinusitis: a new clinical entity of nasal disease. Acta Otolaryngol (2010) 1.04
Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease. J Hepatol (2008) 1.03
Long-term follow-up of autoimmune pancreatitis: characteristics of chronic disease and recurrence. Clin Gastroenterol Hepatol (2009) 1.03